SOOIL DEVELOPMENT CO., LTD.

SOOIL Development Co., Ltd. is a medical device manufacturer specializing in insulin pump therapy systems for diabetes management. The company designs and markets subcutaneous insulin infusion pumps that deliver insulin with high precision and accuracy, enabling improved diabetes control and patient quality of life. The flagship product line is DANA Diabecare, featuring discreet pump designs with remote control capabilities to enhance patient acceptance and ease of use. SOOIL also offers digital health integration through AnyDana, an Android smartphone application that connects to their insulin pump systems for remote monitoring and management. The company participates actively in major diabetes care conferences including the American Diabetes Association annual meeting, European Association for the Study of Diabetes (EASD), and International Conference on Diabetes Management (ICDM), demonstrating commitment to clinical research and professional engagement. Products undergo regulatory compliance processes for multiple markets. The company serves patients and healthcare providers worldwide with a focus on improving subcutaneous insulin delivery accuracy and patient convenience. Manufacturing and distribution capabilities extend to North America through a US-based office.